Aveanna Healthcare (AVAH) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
17 Apr, 2026Executive summary
Annual meeting scheduled for May 29, 2026, at the Atlanta headquarters.
Proxy materials, including the Proxy Statement and 2025 Annual Report, are available online or by request.
Stockholders of record as of April 6, 2026, are eligible to vote.
Voting matters and shareholder proposals
Election of three Class II director nominees for three-year terms expiring at the 2029 annual meeting.
Ratification of Ernst & Young LLP as independent auditors for the fiscal year ending January 2, 2027.
Advisory, non-binding vote on executive compensation for named executive officers.
Authorization for proxies to vote on any other business properly presented at the meeting.
Board of directors and corporate governance
Director nominees: Rodney D. Windley, Sam Weil, and Steven E. Rodgers.
Latest events from Aveanna Healthcare
- Strong financial results, board elections, auditor ratification, and executive pay up for vote.AVAH
Proxy filing17 Apr 2026 - Strong revenue growth and value-based care drive expansion in a $119bn homecare market.AVAH
Investor presentation20 Mar 2026 - Double-digit revenue and profit growth in 2025, robust 2026 outlook, major acquisition announced.AVAH
Q4 202519 Mar 2026 - Q2 revenue up 7% to $505M, adjusted EBITDA up 27%, guidance raised despite lower net income.AVAH
Q2 20242 Feb 2026 - Strategic transformation and rate wins drive growth, staffing, and margin expansion in 2024.AVAH
Healthcare Services Conference1 Feb 2026 - Accelerating growth via preferred payer strategy, targeting $200M EBITDA by 2026.AVAH
Jefferies Global Healthcare Conference1 Feb 2026 - 2025 guidance raised as transformation and Q3 results drive scalable, value-based growth.AVAH
44th Annual J.P. Morgan Healthcare Conference16 Jan 2026 - Q3 revenue up 6.5%, adjusted EBITDA rose 32.2%, and guidance was raised for 2024.AVAH
Q3 202416 Jan 2026 - Strategic transformation and efficiency drive growth, margin expansion, and strong cash flow.AVAH
43rd Annual J.P. Morgan Healthcare Conference 202510 Jan 2026